Reprogramming the wonder drug rapamycin allows creation of new small-molecule drugs

In the new study, the authors aimed to reprogram rapamycin by keeping the parts of rapamycin and tacrolimus that bind FKBP12 and changing the remaining half of the molecule in order to target completely new disease-associated proteins beyond mTOR and calcineurin.

from Health & Medicine News -- ScienceDaily https://ift.tt/2BZbUnD

Comments

Popular posts from this blog

New 3D imaging and visualization technique provides detailed views of muscle architecture

Splints // Types